510(k) K223465
K223465 is an FDA 510(k) premarket notification submitted by Radiance Therapeutics, Inc. for the device "RadianceTx Radionuclide Brachytherapy Source". The FDA issued a decision of Substantially Equivalent on Jan 11, 2023. The device falls under product code KXK (Source, Brachytherapy, Radionuclide), a Class II device regulated under 21 CFR 892.5730.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jan 11, 2023
- Date Received
- Nov 17, 2022
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Source, Brachytherapy, Radionuclide
- Device Class
- Class II
- Regulation Number
- 892.5730
- Review Panel
- RA
- Submission Type
- 510(k)
Need the full FDA record for Radiance Therapeutics, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.